Commentary: New Class of Drugs Shifts Momentum on Alzheimer’s
A new Alzheimer’s drug is expected to be approved by the Food and Drug Administration (FDA). However, the medication works best mostly for those in the earliest stages of Alzheimer’s.
University of California San Francisco
Give to UCSFA new Alzheimer’s drug is expected to be approved by the Food and Drug Administration (FDA). However, the medication works best mostly for those in the earliest stages of Alzheimer’s.
Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, but remained high for those living at home.
A rare burst of visual creativity is seen occasionally in patients with frontotemporal dementia. A UCSF-led study offers new insights into how this talent develops as key areas of the brain degenerate.
UCSF is helping to create the first large group of Asian American study participants to help improve Alzheimer’s disease care for the Asian community North America.
A large, collaborative study on multiple sclerosis (MS) severity found that a single gene variant is predictive of much faster neurodegeneration in MS patients.
With the help of a $33.7 million state grant, the San Francisco Department of Public Health (SFDPH) and ZSFG plan to introduce new inpatient and outpatient mental health services for San Francisco youth.
The advent of cheap, easy-to-use blood tests for Alzheimer’s disease has the potential to revolutionize diagnosis and treatment. But they also raise difficult questions that the field is only beginning to consider.
A new treatment approach draws on research into the unique teenage brain.
UCSF researchers developed an approach to measure an over-the-counter allergy medication’s effectiveness in repairing brain damage from multiple sclerosis (MS), making it possible to also assess future therapies for the disorder.
As mental health needs rise in California, the UCSF Child & Adolescent Psychiatry Portal (CAPP) helps educate and train primary care physicians and pediatrics to provide support to patients with psychiatric needs.
UCSF researchers tested nitroglycerin patches, an treatment for chest pain from coronary artery disease, for menopausal hot flashes. Short-term benefits were seen, but not long-term as some side effects occurred.
UCSF researchers discover how gabapentin interacts with calcium channels, opening doors for more effective treatments in epilepsy and Lupus by influencing channel biogenesis.
In partnership with UCSF, Citywide Case Management supports vulnerable residents with mental illness in San Francisco, providing integrated care and essential services to transform lives and create paths to recovery.
In a first, researchers have identified chronic pain pathways in individuals directly from their neural activity, showing promising paths forward for treatment.
School-based clinics in Oakland provide comprehensive primary and mental health care to underserved students. Staffed by UCSF Benioff Children's Hospital Oakland, these clinics offer services from medical checkups to therapy, benefiting students' overall well-being and academic success.
With the help of philanthropic support, UCSF Benioff Children’s Hospital Oakland opened a new behavioral health clinic for children.
Exposure to trichloroethylene (TCE), a chemical found in the air, water, and soil, may increase the risk of Parkinson's disease by 70%, according to a UCSF study. TCE is commonly used today as a degreasing solvent.
UCSF scientists have found that brain cancer glioblastoma can cause cognitive decline by affecting neural connections, but the epilepsy drug gabapentin shows promise in blocking this activity, offering hope for new treatments.
Sleep spindles, bursts of brain activity during NREM2 sleep, may regulate anxiety in PTSD, challenging recent studies. Non-invasive therapies could provide relief, such as prescription drugs or electrical brain stimulation. Sleep hygiene is also recommended to maximize the benefit of spindles after a stressful episode.
A traditional African psychedelic plant medicine called ibogaine is the blueprint for two new drug candidates that could treat addiction and depression.
Ten graduate school finalists competed in this year’s UCSF Grad Slam, in which students present their research in three minutes or less in terms easily understood by a general audience.
A newly discovered brain circuit recruits brain cells called astrocytes to calm overactive neurons to produce a calming and relaxing effect.
Pregnant women have a lower risk of gestational diabetes and unhealthy weight gain in cities that tax sugary drinks, according to a first-of-its-kind study of more than 5 million women by UCSF.